African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5182

Full Length Research Paper

A retrospective study of antibiotic sensitivity pattern of uropathogens in the Federal Capital Territory, Nigeria

Michael P. Okoh
  • Michael P. Okoh
  • Department of Medical Biochemistry, Faculty of Basic Medical Sciences, College of Health Sciences, University of Abuja, FCT, Nigeria.
  • Google Scholar
Halima M. Habi
  • Halima M. Habi
  • Department of Microbiology, Faculty of Science, University of Abuja, FCT, Nigeria.
  • Google Scholar
Salamatu S. Machunga-Mambula
  • Salamatu S. Machunga-Mambula
  • Department of Microbiology, Faculty of Science, University of Abuja, FCT, Nigeria.
  • Google Scholar


  •  Received: 25 September 2017
  •  Accepted: 30 November 2017
  •  Published: 14 December 2017

References

Aboderi OA, Abdu A, Odetoyin BW, Lamikaura A (2009). Antimicrobial resistance in E. coli strains from urinary tract infections. J. Nat. Med. Assoc. Niger. 01:1268-1273.

 

Bauer AW, Kirby WMM, Sherris JC, Turck M (1966). Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45:493-496.

 
 

Chaturvedi KS, Hung CS, Giblin DE, Urushidani S, Austin AM, Dinauer MC, Henderson JP (2013). Cupric yersiniabactin is a virulence-associated superoxide dismutase mimic. ACS chemical biology. 9(2):551-5861. PubMed: 24283977
Crossref

 
 

Chen SL, Wu M, Henderson JP, Hooton TM, Hibbing ME, Hultgren SJ, Gordon JI (2013). Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci. Translational Med. 5(184):184ra60.
Crossref

 
 

Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, Ehren I, Hoekfelt T, Gudmundsson G, Gallo R, Agerberth B, Brauner (2006). What keeps the urinary tract sterile? The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12:636-640.
Crossref

 
 

Colgan R, Williams M (2011). Diagnosis and Treatment of Acute Uncomplicated Cystitis. American Family Physician 84(7): 771-776.

 
 

Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB (2013). Recent advances in understanding enteric pathogenic Escherichia coli. Clin. Microbiol. Rev. 26:822-880.
Crossref

 
 

Daoud Z, Afif C (2011). Escherichia coli Isolated from Urinary Tract Infections of Lebanese Patients between 2000 and 2009: Epidemiology and Profiles of Resistance. Chemotherapy and research Practice. 2011.
Crossref

 
 

DeBacker CT, Heytens S, DeSutter A, Stobbering EE, Verschragen G (2008). Evolution of bacterial susceptibility of Esherichia coli inuncomplicated urinary tract infections in a country with high antibiotic consumption: A comparison of two surveys with a ten year interval. J. Antimicrob. Chemother. 62(2):364-368
Crossref

 
 

Duell BL, Carey AJ, Tan CK, et al (2012). Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. J Immunol. 188:781-792. PubMed: 22184725
Crossref

 
 

Foxman B (2003). Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Dis. Mon. 49:53-70. PubMed 12601337
Crossref

 
 

Ho YS, Xiong Y, Ma W, Spector A, Ho DS (2004). Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J. Biol. Chem. 279(31):32804-12.
Crossref

 
 

Kaper JB, Nataro JP, Mobley HL (2004). Pathogenic Escherichia coli. Nature Reviews Microbiol. 2:123-140.
Crossref

 
 

Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, Babatunde SK (2009). Prevalence of Urinary Tract Infections (UTI) among Patients Attending Dalhatu Araf Specialist Hospital, Lafia, Nasarawa State, Nigeria. Int. J. Med. Med. Sci. 1(5):163-167.

 
 

Lane DR, Takhar SS (2011). Diagnosis and Management of Urinary Tract Infection and Pyelonephritis. Emergency Med. Clinics of North Am. 29(3):539-542.

 
 

Liza DT, Jonathan O (2006). Urinary Tract Infections: Causes, Symptoms and Treatment. Am. J. Epidemiol 132:328-337.

 
 

Mambula SS, Simons E, Hastey R, Selsted ME, Levitz SM (2000). Human Neutrophil-mediated Nonoxidative Antifungal Activity Against Cryptococcus neoformans. Infec. Immun, 68:6257-6264.
Crossref

 
 

Mbata TI (2007). Prevalence and Antibiogram of UTIs among Prisons Inmates in Nigeria. Int. J. Microbiol 3(2):11-15.

 
 

Morrison G, Kilanowski F, Davidson D, Dorin J (2002,). Characterization of the mouse beta defensing 1, Defbi, mutant mouse model. Infect. Immun. 70:3053-3060. PubMed:12010997
Crossref

 
 

News.sky.com (2016). http://news.sky.com/story/jeremy-hunt-gives-nhs-hospitals-extra-cash-to-fight-superbugs-such-as-ecoli-10647804

 
 

Nielsen KL, Dynesen P, Larsen P, Jakobsen L, Andersen PS, Frimodt-Møller N (2014). Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections. Infect. Immun. 82(4):1572-1578. PubMed: 24452682
Crossref

 
 

Nicolle LE (2008). Uncomplicated urinary tract infection in adult including uncomplicated Pylonephritis. J. North Am. Urol. 35(1):1-2.
Crossref

 
 

Nwachukwu KC, Asagba SO, Nwose C, Okoh MP (2014). Radiation protection and anti-oxidative effects of garlic, onion and ginger extracts, x-ray exposed albino rats as model for biochemical studies. Afri. Jnl. Biochem. Res 8(9):166-173.
Crossref

 
 

O'Brien VP, Hannan TJ, Schaefferc AJ, Hultgrena SJ (2015). Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr. Opin Infect. Dis. 28(1):97-105.
Crossref

 
 

Paragas N, Kulkarni R, Werth M, et al (2014). Alpha – Intercalated cells defend the urinary system from bacterial infection. J. Clin. Invest. 124: 2963- 2976, PubMed: 24937428
Crossref

 
 

Robinson K, Hotopp D (2016). Bacteria and humans have been swapping DNA for millennia. The Scientist, (http://mobile.the-scientist.com/article/47125/bacteria-and-humans-have-been-swapping-dna-for-millennia)

 
 

Samuel SO, Salami TAT, Adewuyi GM, Babatope E, Ekozien MI (2012). Prevalence of Urinary Tract Infections among a cohort of HIV Positive Patients accessing care in a rural health centre in Nigeria. J. Microbiol. Biotechnol. Res 2 (4):507-510.

 
 

Schappert SM, Rechtsteiner EA (2007). Ambulatory medical care utilization estimates for Vital Health Stat 13:1-38.

 
 

Servin AL (2014). Pathogenesis of Human Diffusely Adhering Escherichia coli Expressing Afa/Dr Adhesins (Afa/Dr DAEC): Current Insights and Future Challenges. Clin. Microbiol. Rev. 27(4):823.
Crossref

 
 

Sharef SW, El-Naggari M, Al-Nabhani D, Al Sawai A, Al Muharrmi Z, Elnour I (2015). Incidence of antibiotics resistance among uropathogens in Omani children presenting with a single episode of urinary tract infection. J. Infect Public Health 8:458-465.
Crossref

 
 

Silva ON, De La Fuente-nú-ez C, Haney EF, Fensterseifer IC, Ribeiro SM, Porto WF, Brown P, Faria-Junior C, Rezende TM, Moreno SE, Lu TK (2016). An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities. Scientific reports. 6.
Crossref

 
 

Smith NJ, Varley CL, Eardley I, Feather S, Trejdosiewicz LK, Southgate J (2011). Toll-like receptor responses of normal human urothelial cells to bacterial flagellin and lipopolysaccharide. The Journal of urology. 186(3):1084-1092. PubMed 21784459
Crossref

 
 

Taneja N, Rao P, Arora J, and Dogra A (2008). Occurrence of ESBL & Amp – C beta – lactamase & susceptibility to newer antimicrobial agents in complicated UTI. Indian J. Med. Res. 127:85-88. PubMed 18316858

 
 

Tadesse DA, Zhao S, Tong E, Ayers S, Singh A, Bartholomew MJ, McDermott PF (2012). Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950–2002. Emerging infectious diseases. 18(5):741.
Crossref

 
 

Thumbikat P, Waltenbaugh C, Schaeffer AJ, Klumpp DJ (2006). Antigen – specific responses accelerate bacterial clearance in the bladder. J. Immunol. 176:3080-3086. PubMed: 16493067
Crossref

 
 

Wright GD (2011). Molecular mechanisms of antibiotic resistance. Chem. Commun. 47:4055-4061.
Crossref